MENU
+Compare
BHC
Stock ticker: NYSE
AS OF
Nov 19, 02:00 PM (EDT)
Price
$6.06
Change
-$0.12 (-1.94%)
Capitalization
2.29B

BHC Bausch Health Companies Forecast, Technical & Fundamental Analysis

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets... Show more

BHC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BHC with price predictions
Nov 18, 2025

BHC in downward trend: price dove below 50-day moving average on November 14, 2025

BHC moved below its 50-day moving average on November 14, 2025 date and that indicates a change from an upward trend to a downward trend. In of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BHC as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BHC turned negative on November 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BHC broke above its upper Bollinger Band on October 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BHC entered a downward trend on October 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BHC's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for BHC crossed bullishly above the 50-day moving average on November 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHC advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.491). P/E Ratio (6.371) is within average values for comparable stocks, (71.901). BHC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.834). BHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.230) is also within normal values, averaging (55.234).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BHC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BHC is expected to report earnings to rise 160.42% to $1.25 per share on February 25

Bausch Health Companies BHC Stock Earnings Reports
Q4'25
Est.
$1.25
Q3'25
Missed
by $0.56
Q2'25
Beat
by $0.36
Q1'25
Missed
by $0.26
Q4'24
Beat
by $0.02
The last earnings report on October 29 showed earnings per share of 47 cents, missing the estimate of $1.04. With 244.91K shares outstanding, the current market capitalization sits at 2.29B.
A.I.Advisor
published Dividends

BHC paid dividends on December 22, 2010

Bausch Health Companies BHC Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of December 22, 2010, and an ex-dividend date of November 10, 2010. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2150 Saint Elzear Boulvard West
Phone
+1 514 744-6792
Employees
20270
Web
https://www.bauschhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWOHX63.96N/A
N/A
MFS Global Growth R3
TLVAX23.19N/A
N/A
Timothy Plan Large/Mid Cap Value A
RSMOX23.44N/A
N/A
Victory RS Mid Cap Growth A
LSGRX32.65-0.22
-0.67%
Loomis Sayles Growth Y
INGIX20.62-0.17
-0.82%
Voya US Stock Index Port I

BHC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BHC has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.82%
AMRX - BHC
39%
Loosely correlated
-0.04%
AMPH - BHC
35%
Loosely correlated
-0.46%
VTRS - BHC
31%
Poorly correlated
+0.47%
NBIX - BHC
28%
Poorly correlated
-3.44%
TEVA - BHC
26%
Poorly correlated
+1.02%
More

Groups containing BHC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.82%
Pharmaceuticals: Generic
industry (214 stocks)
32%
Poorly correlated
-0.12%